P-gp/BCRP-IN-1
P-gp/BCRP-IN-1 (compound 19) is a potential, relatively safe, orally active and efficient efflux transporter (P-gp and BCRP) inhibitor. P-gp/BCRP-IN-1 exerts resistance reversal by inhibiting the efflux function of P-gp and BCRP. P-gp/BCRP-IN-1 can overcome the resistance and improve the oral bioavailability of PTX (Paclitaxel) [1].
Product Specifications
CAS Number
2764596-06-5
UNSPSC
12352005
Target
BCRP
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/p-gp-bcrp-in-1.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=NN(C(C2=CC=CC=C21)=O)C3=CC=C(C=C3)Cl)NC4=CC=C(C=C4)CCN5CCOCC5
Molecular Formula
C27H25ClN4O3
Molecular Weight
488.97
References & Citations
[1]Shi W, Zhang P, Zou F, et al. Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel. Eur J Med Chem. 2022;233:114231.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSV030310-01 50 µg
Recombinant SARS-CoV-2 S Protein RBD (C-mFc) V2
Sign In for Pricing
View Details PKSV030310-02 500 µg
Recombinant SARS-CoV-2 S Protein RBD (C-mFc) V2
Sign In for Pricing
View Details 
